Hoechst Pakistan Limited HPL
Rs 4,002.00
Vol15Updated10:3029 Jul 2026
01—At a Glance
The headline take on HPL — valuation, income, returns, and efficiency
Consolidated snapshot
02—Price & Performance
Closing prices across timeframes, returns, and range context
HPL — Price History
Daily closing series · toggle period below
03—Key Metrics
Valuation, profitability, structure, and risk in one grid
04—Dividend History & Yield
Payout track record, yield trend, and upcoming distribution
HPL has paid Rs 240.00 per share in cash dividends over the trailing 12 months — a 6.0% yield at the last close. Its most recent payout was Rs 190.00/share, announced 18 Feb 2026 with book closure from 02 Apr 2026. Annual dividend-per-share history back to 2016 is charted below.
Latest Payout
Dividend Per Share Trend
Payout History
Source: PSX company payouts
| Announced | For Period | Type | Amount | Book Closure |
|---|---|---|---|---|
| 18 Feb 2026 | 31 Dec 2025 (YR) | Cash | Rs 190.00(1900%) | 02 Apr 2026 – 08 Apr 2026 |
| 13 Aug 2025 | 30 Jun 2025 (HYR) | Cash | Rs 50.00(500%) | 26 Aug 2025 – 27 Aug 2025 |
| 20 Feb 2025 | 31 Dec 2024 (YR) | Other | 1100% | 02 Apr 2025 – 08 Apr 2025 |
05—Financials & Earnings
Income, balance sheet, and key ratios from published accounts
HPL's market capitalisation stands at Rs 38.60B as of 29 Jul 2026 — up 29.5% over the past 12 months (from Rs 29.81B).
Financial Statements
How OGDC's income and balance sheet have evolved
| PKR Millions | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | Trend |
|---|---|---|---|---|---|---|---|
| Net Sales / Revenue | 30,929 | 26,748 | 21,369 | 18,560 | 15,881 | 14,108 | |
| Cost of Sales | 19,631 | 18,320 | 15,843 | 13,689 | 11,758 | 10,303 | |
| Gross Profit | 11,297 | 8,428 | 5,526 | 4,871 | 4,123 | 3,805 | |
| Administrative Expenses | 998 | 1,074 | 820 | 752 | 522 | 573 | |
| Operating Profit | 5,752 | 4,025 | 2,065 | 1,506 | 1,679 | 1,254 | |
| EBITDA | 6,105 | 4,334 | 2,380 | 1,792 | 2,016 | 1,611 | |
| Other Income | 289 | 234 | 387 | 180 | 170 | 50 | |
| Financial Charges | 100 | 145 | 175 | 50 | 28 | 58 | |
| Profit Before Tax | 4,964 | 3,479 | 916 | 724 | 1,436 | 880 | |
| Taxation | 2,054 | 1,622 | 555 | 557 | 530 | 387 | |
| Profit After Tax | 2,910 | 1,857 | 361 | 167 | 906 | 493 | |
| EPS - Basic (Rs) | Rs 301.67 | Rs 192.56 | Rs 37.41 | Rs 17.29 | Rs 93.93 | Rs 51.12 |
All figures in PKR millions from published accounts.
Profitability & Returns
Margins, returns on capital, and earnings per share
Latest · FY25
| Ratio | Value |
|---|---|
| Net profit margin | 9.4% |
| Gross profit margin | 36.5% |
| EBITDA margin | 19.7% |
| EBIT margin | 18.6% |
Net profit margin
Net profit ÷ revenue · %
Financial Health
Coverage, leverage, and the strength of the balance sheet
Latest · FY25
| Ratio | Value |
|---|---|
| Effective tax rate | 41.4% |
Effective tax rate
Taxation ÷ profit before tax · %
Market cap trajectory
Close × current shares outstanding · current Rs 38.60B
Valuation & Capital Returns
What the market is paying for HPL, and what it returns to shareholders
Latest · FY25
| Ratio | Value |
|---|---|
| Price to earnings | 13.92x |
| Price to sales | 1.31x |
Price to earnings
Period-end price ÷ EPS · times
06—Technical Analysis
Trading signal, moving averages, momentum, and key levels
10-day SMA (Rs 4040.07) is above the 30-day SMA (Rs 4020.28). RSI at 45 sits in the neutral band.
Moving AverageThe average close over a set window (10/30/200 days) — smooths daily noise to reveal the trend.Read the full guide →
| Period | Value | vs Current | Position |
|---|---|---|---|
| SMA 10 | Rs 4,040.07 | +0.95% | Below |
| SMA 30 | Rs 4,020.28 | +0.46% | Below |
| SMA 60 | Rs 4,012.54 | +0.26% | Below |
| SMA 200 | Rs 4,140.93 | +3.47% | Below |
At 45, momentum sits within the neutral band (30–70), suggesting balanced buying and selling pressure.
- MACD6.19
- Signal7.53
- Histogram-1.34
07—Leverage Insights
MTS, margin financing, futures open interest, and combined exposure
No leverage exposure reported
HPL is not currently financed through MTS or margin financing (MFS), and shows no futures open interest or blank sales on the latest NCCPL/PSX reports.
08—Settlement Insights
UIN-wise settlement concentration and price context
Metrics and charts over the selected trailing window
Settlement % Trajectory
Solid = UIN settlement % · Dashed = 14-session EMA
As of 16 Jul 2026
Price vs Settlement
Close price (left axis) · UIN settlement % (right axis)
10—About the Company
Business description, governance, and corporate information
Hoechst Pakistan Limited is a public limited Company incorporated in Pakistan under the repealed Companies Act, 1913 (Now the Companies Act, 2017). The Company is engaged in the manufacturing, selling and trading of pharmaceutical and related products. The Company has changed its name from Sanofi-Aventis Pakistan Limited to Hoechst Pakistan Limited.
Corporate Information
- RegistrarFAMCO Share Registration Services (Private) Limited, 8-F, Near Hotel Faran, Nursery Block-6, P.E.C.H.S., Shahrah-e-Faisal, Karachi
- AuditorM/s/ A.F. Ferguson & Co. Chartered Accountants
- Websitewww.hoechst.com.pk
- AddressPlot No 23, Sector 22 Korangi Industrial Area Karachi, Pakistan.
- SectorPharmaceuticals
- Financial Year EndDecember
Key People
| Name | Role |
|---|---|
SISajjad Iftikhar | CEO |
SBSyed Babar Ali | Chairperson |
SMSyed Muhammad Taha Naqvi | Company Secretary |
Reports & Filings
- Quarterly Report — 31 Mar 2026PDF
- Quarterly Report — 30 Sept 2025PDF
- Quarterly Report — 30 Jun 2025PDF
- Quarterly Report — 31 Mar 2025PDF
- Annual Report FY2025PDF
- Quarterly Report — 30 Sept 2024PDF
- Quarterly Report — 30 Jun 2024PDF
- Quarterly Report — 31 Mar 2024PDF
Sourced from official PSX financial-report submissions.
11—Recent Announcements
Latest company filings as reported on PSX
Filings and disclosures from the PSX announcement feed
- 12 Jun 2026Others
- 25 May 2026Others
- 21 May 2026Board Meetings
- 14 May 2026Management Change
- 13 May 2026Others
- 30 Apr 2026Board Meetings
- 30 Apr 2026Board Meetings
- 29 Apr 2026Report
12—Peers in Pharmaceuticals
How the cohort is moving — same-sector stocks by market cap
HPL vs Pharmaceuticals sector median
| Metric | HPL | Sector median |
|---|---|---|
| P/E RatioShare price ÷ earnings per share — the price you pay for each rupee of annual profit. Compare within a sector.Read the full guide → | 13.3x | 16.0x |
| Dividend YieldTrailing-12-month cash dividends ÷ share price. A high yield can signal income — or a falling price.Read the full guide → | 6.0% | 4.0% |
| Return on EquityNet profit ÷ shareholders' equity — how hard the company works each rupee investors have put in.Read the full guide → | 38.8% | 22.3% |
| 1-Year Return | +29.2% | -8.7% |
| Market CapitalisationShare price × total shares — the company's full market value, and the basis for index weightings.Read the full guide → | Rs 38.60B | Rs 27.79B |
Pharmaceuticals · sector heat
13—Frequently Asked Questions
The most common questions investors ask about HPL
Frequently Asked Questions
HPL closed at Rs 4,002.00 on 29 Jul 2026, down 1.06% on the day, within a 52-week range of Rs 2,925.66–4,889.99. Prices on this page refresh through the trading day; log in to BSL for live quotes.
Hoechst Pakistan Limited is a public limited Company incorporated in Pakistan under the repealed Companies Act, 1913 (Now the Companies Act, 2017). See About the Company on this page for the full profile, management, and corporate information.
HPL has paid Rs 240.00 per share in cash dividends over the trailing 12 months — a 6.0% yield at the last close. Review the payout history in the Dividends section and compare with the highest dividend yield stocks on PSX.
No upcoming payout is announced yet. The most recent was a payout of Rs 190.00 per share with book closure from 02 Apr 2026. New announcements appear on this page and on the PSX ex-dates calendar.
Yes — Hoechst Pakistan Limited is on the PSX's Shariah-compliant (KMI All Shares) list. Browse all Shariah-compliant PSX stocks.
HPL trades at 13.3x earnings against a Pharmaceuticals median of 16.0x, with a 6.0% dividend yield versus 4.0%. The full comparison table and peer list are in the Peers section, or explore the Pharmaceuticals sector page.
Annual reports for FY2025 are linked under Reports & Filings in the About section of this page, sourced from official PSX submissions.
Open a BSL trading account, fund it, and place your HPL order on the Pakistan Stock Exchange — account opening takes minutes online, with PSX execution, research, and concierge support included.
Quotes and metrics refresh on a regular cadence through the trading day and after the close. For streaming real-time PSX prices and order placement, log in to your BSL account.
Ready to invest in HPL?
Open a BSL trading account in under 10 minutes
Buy and sell HPL and 550+ other PSX-listed stocks with low commissions, real-time data, and a concierge research desk backing every trade.